Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:2610-2616

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huber, S. A.
Right arrow Articles by Tracy, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huber, S. A.
Right arrow Articles by Tracy, R. P.
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology

(Circulation. 2001;103:2610.)
© 2001 American Heart Association, Inc.


Basic Science Reports

T Helper–Cell Phenotype Regulates Atherosclerosis in Mice Under Conditions of Mild Hypercholesterolemia

S. A. Huber, PhD; P. Sakkinen, MD; C. David, MD; M. K. Newell, PhD; R. P. Tracy, PhD

From the Departments of Pathology (S.A.H., P.S., R.P.T.), Biochemistry (R.P.T.), and Medicine (M.K.N.), University of Vermont, Burlington, and the Department of Immunology, Mayo Clinic, Rochester, Minn (C.D.).

Correspondence to Sally Ann Huber, PhD, Department of Pathology, University of Vermont, 208 S Park Dr, Suite 2, Colchester, VT 05446. E-mail shuber{at}salus.uvm.edu

Background—T cells are implicated in atherosclerosis, but little is known about the genetic control or molecular pathways, especially under conditions of mild hypercholesterolemia.

Methods and Results—BALB/c mice, making a CD4+ Th2 (IL-4+) cell response, express both MHC class II antigens (IAd, IEd) and are atherosclerosis-resistant. C57Bl/6 mice produce a CD4+ Th1 (interferon [IFN]{gamma}+) response, express IAb but no IE, and are atherosclerosis-prone. To evaluate T helper–cell phenotype in fatty streak formation, wild-type C57Bl/6 mice (IAb+IE-) and transgenic mice, either ABo, IAb-IE-; ABE{alpha}, IA-IEk+; or Bl.Tg.E{alpha}, IAb+IEk+, were fed a high-cholesterol diet for 16 weeks and evaluated histomorphometrically for aortic lesions. Lesion size in ABo, ABE{alpha}, and Bl.Tg.E{alpha} strains was decreased by 54%, 79%, and 82%, respectively, compared with wild-type, correlating with decreased Th1 and increased Th2 expression and suggesting that T helper–cell phenotype is important in fatty lesion development. Decreasing Th1 cells by antibodies ({alpha}-CD4) or cytokines (IL-4) also caused >=80% reductions in lesion size. Immunohistology revealed IFN-{gamma}, but not IL-4, colocalized with activated macrophages. Confirming these findings in a different mouse strain, BALB/c Stat 6 knockout mice (Th2 cell–deficient) developed aortic lesions comparable to C57Bl/6 mice on the same diet.

Conclusions—In mildly hypercholesterolemic C57Bl/6 mice, presence of IAb and absence of IE regulated CD4+ T helper–cell phenotype; fatty lesions were proportional to IFN{gamma}+ Th1 cells in both C57Bl/6 and BALB/c strains. IFN-{gamma} may participate through macrophage activation, whereas IL-4 may act to limit Th1-cell response.


Key Words: arteriosclerosis • immunology • lipids




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J. A. Kelly, M. E. Griffin, R. A. Fava, S. G. Wood, K. A. Bessette, E. R. Miller, S. A. Huber, C. J. Binder, J. L. Witztum, and P. M. Morganelli
Inhibition of arterial lesion progression in CD16-deficient mice: evidence for altered immunity and the role of IL-10
Cardiovasc Res, January 1, 2010; 85(1): 224 - 231.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Z. Mallat, S. Taleb, H. Ait-Oufella, and A. Tedgui
The role of adaptive T cell immunity in atherosclerosis
J. Lipid Res., April 1, 2009; 50(Supplement): S364 - S369.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Y. Stokes, L. Calahan, C. M. Hamric, J. M. Russell, and D. N. Granger
CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation
Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H689 - H697.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Kleemann, S. Zadelaar, and T. Kooistra
Cytokines and atherosclerosis: a comprehensive review of studies in mice
Cardiovasc Res, August 1, 2008; 79(3): 360 - 376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. M. Wolfort, K. Y. Stokes, and D. N. Granger
CD4+ T lymphocytes mediate hypercholesterolemia-induced endothelial dysfunction via a NAD(P)H oxidase-dependent mechanism
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2619 - H2626.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Schulte, G. K. Sukhova, and P. Libby
Genetically Programmed Biases in Th1 and Th2 Immune Responses Modulate Atherogenesis
Am. J. Pathol., June 1, 2008; 172(6): 1500 - 1508.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Rogers, S. Burchat, J. Gage, M. Hasu, M. Thabet, L. Wilcox, T. A. Ramsamy, and S. C. Whitman
Deficiency of invariant V{alpha}14 natural killer T cells decreases atherosclerosis in LDL receptor null mice
Cardiovasc Res, April 1, 2008; 78(1): 167 - 174.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. L. King, L. A. Cassis, and A. Daugherty
Interleukin-4 Does Not Influence Development of Hypercholesterolemia or Angiotensin II-Induced Atherosclerotic Lesions in Mice
Am. J. Pathol., December 1, 2007; 171(6): 2040 - 2047.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Y. Stokes, S. Gurwara, and D. N. Granger
T-Cell-Derived Interferon-{gamma} Contributes to Arteriolar Dysfunction During Acute Hypercholesterolemia
Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1998 - 2004.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A.-K. L. Robertson and G. K Hansson
T Cells in Atherogenesis: For Better or For Worse?
Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2421 - 2432.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Zernecke, E. A. Liehn, J.-L. Gao, W. A. Kuziel, P. M. Murphy, and C. Weber
Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10
Blood, June 1, 2006; 107(11): 4240 - 4243.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev, April 1, 2006; 86(2): 515 - 581.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
V. da Cunha, B. Martin-McNulty, J. Vincelette, L. Zhang, J. C. Rutledge, D. W. Wilson, R. Vergona, M. E. Sullivan, and Y.-X. Wang
Interaction between mild hypercholesterolemia, HDL-cholesterol levels, and angiotensin II in intimal hyperplasia in mice
J. Lipid Res., March 1, 2006; 47(3): 476 - 483.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S G Baidya and Q-T Zeng
Helper T cells and atherosclerosis: the cytokine web
Postgrad. Med. J., December 1, 2005; 81(962): 746 - 752.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
V. C. Mehra, V. S. Ramgolam, and J. R. Bender
Cytokines and cardiovascular disease
J. Leukoc. Biol., October 1, 2005; 78(4): 805 - 818.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. W. Homeister, A. Daugherty, and J. B. Lowe
{alpha}(1,3)Fucosyltransferases FucT-IV and FucT-VII Control Susceptibility to Atherosclerosis in Apolipoprotein E-/- Mice
Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1897 - 1903.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Nakai, K. Iwabuchi, S. Fujii, N. Ishimori, N. Dashtsoodol, K. Watano, T. Mishima, C. Iwabuchi, S. Tanaka, J. S. Bezbradica, et al.
Natural killer T cells accelerate atherogenesis in mice
Blood, October 1, 2004; 104(7): 2051 - 2059.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Y. Stokes, E. C. Clanton, K. P. Clements, and D. N. Granger
Role of Interferon-{gamma} in Hypercholesterolemia-Induced Leukocyte-Endothelial Cell Adhesion
Circulation, April 29, 2003; 107(16): 2140 - 2145.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. Ducloux, B. Challier, P. Saas, P. Tiberghien, and J.-M. Chalopin
CD4 Cell Lymphopenia and Atherosclerosis in Renal Transplant Recipients
J. Am. Soc. Nephrol., March 1, 2003; 14(3): 767 - 772.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
D. E. Bild, D. A. Bluemke, G. L. Burke, R. Detrano, A. V. Diez Roux, A. R. Folsom, P. Greenland, D. R. JacobsJr., R. Kronmal, K. Liu, et al.
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
Am. J. Epidemiol., November 1, 2002; 156(9): 871 - 881.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. K. Hansson, P. Libby, U. Schonbeck, and Z.-Q. Yan
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
Circ. Res., August 23, 2002; 91(4): 281 - 291.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Huber, C. Shi, and R. C. Budd
{gamma}{delta} T Cells Promote a Th1 Response during Coxsackievirus B3 Infection In Vivo: Role of Fas and Fas Ligand
J. Virol., July 1, 2002; 76(13): 6487 - 6494.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Daugherty and D. L. Rateri
T Lymphocytes in Atherosclerosis: The Yin-Yang of Th1 and Th2 Influence on Lesion Formation
Circ. Res., May 31, 2002; 90(10): 1039 - 1040.
[Full Text] [PDF]


Home page
Circ. Res.Home page
S. C. Whitman, P. Ravisankar, and A. Daugherty
Interleukin-18 Enhances Atherosclerosis in Apolipoprotein E-/- Mice Through Release of Interferon-{gamma}
Circ. Res., February 8, 2002; 90 (2): e34 - e38.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. C. Whitman, P. Ravisankar, and A. Daugherty
Interleukin-18 Enhances Atherosclerosis in Apolipoprotein E-/- Mice Through Release of Interferon-{gamma}
Circ. Res., February 8, 2002; 90 (2): e34 - e38.
[Abstract] [Full Text] [PDF]